Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death
Public ClinicalTrials.gov record NCT00993382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Primary objective was to assess the efficacy of Celivarone for the prevention of Implantable Cardioverter Defibrillator (ICD) interventions or death. Secondary objectives were: * To assess the tolerability and safety of the different dose regimens of Celivarone in the selected population. * To document Celivarone plasma levels during the study.
Study identification
- NCT ID
- NCT00993382
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 486 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- May 2011 (Actual)
- Last update posted
- May 30, 2016
2009 – 2011
United States locations
- U.S. sites
- 37
- U.S. states
- 20
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840006 | Huntsville | Alabama | 35801 | — |
| Investigational Site Number 840042 | Mobile | Alabama | 36608 | — |
| Investigational Site Number 840014 | Mesa | Arizona | 85206 | — |
| Investigational Site Number 840032 | Phoenix | Arizona | 85006 | — |
| Investigational Site Number 840033 | Tucson | Arizona | 85723 | — |
| Investigational Site Number 840054 | Redondo Beach | California | 90277 | — |
| Investigational Site Number 840007 | Redwood City | California | 94062 | — |
| Investigational Site Number 840039 | Colorado Springs | Colorado | 80909 | — |
| Investigational Site Number 840002 | Fort Myers | Florida | 33908 | — |
| Investigational Site Number 840010 | Orlando | Florida | 32806 | — |
| Investigational Site Number 840005 | Port Charlotte | Florida | 33952-8008 | — |
| Investigational Site Number 840013 | St. Petersburg | Florida | 33707 | — |
| Investigational Site Number 840043 | St. Petersburg | Florida | 33707 | — |
| Investigational Site Number 840004 | Augusta | Georgia | 30901 | — |
| Investigational Site Number 840045 | Chicago | Illinois | 60637 | — |
| Investigational Site Number 840035 | Lombard | Illinois | 60148 | — |
| Investigational Site Number 840017 | Kansas City | Kansas | 66160 | — |
| Investigational Site Number 840022 | Scarborough | Maine | 04074 | — |
| Investigational Site Number 840009 | Ann Arbor | Michigan | 48109-0759 | — |
| Investigational Site Number 840026 | Detroit | Michigan | 48236 | — |
| Investigational Site Number 840003 | Petoskey | Michigan | 49770 | — |
| Investigational Site Number 840015 | Ypsilanti | Michigan | 48197 | — |
| Investigational Site Number 840049 | Columbia | Missouri | 65201 | — |
| Investigational Site Number 840019 | Kansas City | Missouri | 64114 | — |
| Investigational Site Number 840031 | New York | New York | 10001 | — |
| Investigational Site Number 840029 | Tulsa | Oklahoma | 74104 | — |
| Investigational Site Number 840037 | Portland | Oregon | 97201-3098 | — |
| Investigational Site Number 840024 | Camp Hill | Pennsylvania | 17011 | — |
| Investigational Site Number 840030 | Doylestown | Pennsylvania | 18901 | — |
| Investigational Site Number 840034 | Upland | Pennsylvania | 19013 | — |
| Investigational Site Number 840020 | Charleston | South Carolina | 29406 | — |
| Investigational Site Number 840048 | Rapid City | South Dakota | 57701 | — |
| Investigational Site Number 840011 | Tullahoma | Tennessee | 37388 | — |
| Investigational Site Number 840025 | Chesapeake | Virginia | 23320 | — |
| Investigational Site Number 840012 | Norfolk | Virginia | 23507 | — |
| Investigational Site Number 840038 | Richmond | Virginia | 23225 | — |
| Investigational Site Number 840016 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00993382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00993382 live on ClinicalTrials.gov.